{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:40:28Z","timestamp":1792122028289,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.bbagen.2013.05.010","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T21:15:10Z","timestamp":1368306910000},"page":"5509-5514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Glycated albumin and diabetes mellitus"],"prefix":"10.1016","volume":"1830","author":[{"given":"Norihiro","family":"Furusyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2013.05.010_bb0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0010","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/diab.44.8.968","article-title":"The relationship of glycaemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial","volume":"44","author":"The Diabetes Control and Complications Trial Research Group","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)12131-1","article-title":"Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group","volume":"354","author":"European Diabetes Epidemiology Group","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0020","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.22.6.920","article-title":"Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study","volume":"22","author":"Tominaga","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jama.290.4.486","article-title":"Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial","volume":"290","author":"Chiasson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0040","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2337\/dc09-9033","article-title":"International committee report on the role of the A1c assay in the diagnosis of diabetes. ADA Workgroup report","volume":"32","author":"The International Expert Committee","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0045","author":"WHO"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0050","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/clinchem\/33.12.2153","article-title":"Fructosamine: structure, analysis, and clinical usefulness","volume":"33","author":"Armbruster","year":"1987","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4093\/dmj.2012.36.2.98","article-title":"The roles of glycated albumin as intermediate glycation index and pathogenic protein","volume":"36","author":"Kim","year":"2012","journal-title":"Diab. Metab. J."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0060","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1073\/pnas.76.9.4258","article-title":"Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus","volume":"76","author":"Guthrow","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1507\/endocrj.K06-103","article-title":"Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control","volume":"54","author":"Takahashi","year":"2007","journal-title":"Endocr. J."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0070","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/clinchem\/47.4.756","article-title":"Effect of hemoglobin variants (Hb J, Hb G, and Hb E) on HbA1c values as measured by cation-exchange HPLC (Diamat)","volume":"47","author":"Tsai","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cca.2009.05.015","article-title":"Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus","volume":"406","author":"Ai","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-8981(02)00207-3","article-title":"An enzymatic method for the measurement of glycated albumin in biological samples","volume":"324","author":"Kouzuma","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1507\/endocrj.K07E-089","article-title":"Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes","volume":"55","author":"Yoshiuchi","year":"2008","journal-title":"Endocr. J."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1507\/endocrj.K09E-234","article-title":"Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM)","volume":"57","author":"Suwa","year":"2010","journal-title":"Endocr. J."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0095","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.clinbiochem.2007.03.022","article-title":"Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus","volume":"40","author":"Lu","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0100","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mas.20090","article-title":"The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update","volume":"25","author":"Lapolla","year":"2006","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0009-8981(86)90212-3","article-title":"Precise measurement of glycated serum albumin by column affinity chromatography and immunoturbidimetry","volume":"161","author":"Reed","year":"1986","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0021-9673(92)80120-J","article-title":"High-performance affinity chromatography system for the rapid, efficient assay of glycated albumin","volume":"597","author":"Yasukawa","year":"1992","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-8981(02)00207-3","article-title":"An enzymatic method for the measurement of glycated albumin in biological samples","volume":"324","author":"Kouzuma","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cccn.2004.02.019","article-title":"Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method","volume":"346","author":"Kouzuma","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03256353","article-title":"Lucica GA-L glycated albumin assay kit: a new diagnostic test for diabetes mellitus","volume":"14","author":"Kohzuma","year":"2010","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1373\/clinchem.2010.150250","article-title":"Determining stability of stored samples retrospectively: the validation of glycated albumin","volume":"57","author":"Nathan","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0135","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1007\/s00125-011-2310-6","article-title":"Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS)","volume":"54","author":"Furusyo","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0140","first-page":"825","article-title":"Report of the Committee on Standardization of Laboratory Testing Related to Diabetes Mellitus of the Japan Diabetes Society: determination of reference intervals of hemoglobin A1c (IFCC) and glycoalbumin in the Japanese population","volume":"49","author":"Tominaga","year":"2006","journal-title":"J. Jpn. Diabetes Soc."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0145","first-page":"178","article-title":"JSCC recommended method for glycated albumin measurement in serum","volume":"37","author":"Committee on Diabetes Mellitus Indices Japan Society of Clinical Chemistry","year":"2008","journal-title":"Jpn. J. Clin. Chem."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cca.2010.10.014","article-title":"Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia","volume":"412","author":"Koga","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1258\/acb.2012.011192","article-title":"Classification of variant forms of haemoglobin according to the ratio of glycated haemoglobin to glycated albumin","volume":"49","author":"Miyazaki","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0160","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2337\/dc09-0836","article-title":"Association between iron deficiency and A1C levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999\u20132006","volume":"33","author":"Kim","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0165","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1681\/ASN.2006070772","article-title":"Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection","volume":"18","author":"Inaba","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0170","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cca.2010.12.013","article-title":"Glycated albumin is independently associated with estimated glomerular filtration rate in nondiabetic patients with chronic kidney disease","volume":"412","author":"Ma","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0175","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1159\/000343920","article-title":"Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis","volume":"36","author":"Murea","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0180","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2337\/dc09-1954","article-title":"A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women","author":"Hashimoto","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0185","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2337\/dc08-0352","article-title":"A1C but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency","volume":"31","author":"Hashimoto","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0190","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2337\/dc09-1954","article-title":"A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women","volume":"33","author":"Hashimoto","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0195","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1464-5491.1999.00093.x","article-title":"Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose","volume":"16","author":"Kilpatrick","year":"1999","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0200","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/dc10-1945","article-title":"Nontraditional markers of glycemia: associations with microvascular conditions","volume":"34","author":"Selvin","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0205","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1742-1241.2011.02755.x","article-title":"Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failure","volume":"65","author":"Lee","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0210","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1507\/endocrj.K07E-089","article-title":"Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes","volume":"55","author":"Yoshiuchi","year":"2008","journal-title":"Endocr. J."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0215","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.2337\/diacare.28.11.2806","article-title":"Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients","volume":"28","author":"Shiraiwa","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6823-12-6","article-title":"Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin","volume":"12","author":"Jones","year":"2012","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1258\/acb.2009.009127","article-title":"Glycated albumin levels are higher relative to glycated haemoglobin levels in gastrectomized subjects","volume":"47","author":"Koga","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0230","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.atherosclerosis.2012.01.019","article-title":"Advanced glycation end-product N\u03b5-carboxymethyl-lysine accelerates progression of atherosclerotic calcification in diabetes","volume":"221","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0235","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/dc10-1945","article-title":"Nontraditional markers of glycemia: associations with microvascular conditions","volume":"34","author":"Selvin","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0240","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0735-1097(01)01783-1","article-title":"Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST)","volume":"39","author":"Sawayama","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.110.953653","article-title":"Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study","volume":"123","author":"Anderson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0250","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.clinthera.2010.07.015","volume":"32","author":"Koyasu","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0255","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/dc09-1009","article-title":"A1C is associated with intima-media thickness in individuals with normal glucose tolerance","volume":"33","author":"Bobbert","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0260","article-title":"Plasma glycated albumin level and atherosclerosis: results from the Kyushu and Okinawa Population Study (KOPS)","author":"Furusyo","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0265","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.atherosclerosis.2012.09.005","article-title":"Serum glycated albumin predicts the progression of carotid arterial atherosclerosis","volume":"225","author":"Song","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0270","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1253\/circj.71.1067","article-title":"Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients","volume":"71","author":"Pu","year":"2007","journal-title":"Circ. J."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0275","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.0000029802.88087.5E","article-title":"A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis","volume":"106","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0735-1097(98)00203-4","article-title":"Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction","volume":"32","author":"Anderson","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0285","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0290","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diabetes.53.3.693","article-title":"Inflammatory markers and risk of developing type 2 diabetes in women","volume":"53","author":"Hu","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdiacomp.2005.06.013","article-title":"The association between metabolic control and prevalent macrovascular disease in type 2 diabetes: the VA Cooperative Study in diabetes","volume":"20","author":"Kirkman","year":"2006","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0300","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","article-title":"The antioxidant properties of serum albumin","volume":"582","author":"Roche","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1096\/fasebj.13.2.233","article-title":"Glucose and free radicals impair the antioxidant properties of serum albumin","volume":"13","author":"Bourdon","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0310","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1016\/j.bbagen.2013.01.019","article-title":"New insights into deleterious impacts of in vivo glycation on albumin antioxidant activities","volume":"1830","author":"Baraka-Vidot","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0315","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1253\/circj.CJ-11-1499","article-title":"Decreased endothelial progenitor cells and increased serum glycated albumin are independently correlated with plaque-forming carotid artery atherosclerosis in type 2 diabetes patients without documented ischemic disease","volume":"76","author":"Moon","year":"2012","journal-title":"Circ. J."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0320","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.diabres.2008.04.012","article-title":"CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases","volume":"81","author":"Koga","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0325","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2009.01.013","article-title":"Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects","volume":"84","author":"Koga","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0330","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2169\/internalmedicine.50.4129","article-title":"Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease","volume":"50","author":"Okada","year":"2011","journal-title":"Intern. Med."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0335","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1021\/pr201030m","article-title":"Low plasma albumin levels are associated with increased plasma protein glycation and HbA1c in diabetes","volume":"11","author":"Bhonsle","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0340","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ki.2008.25","article-title":"Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis","volume":"73","author":"Peacock","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0345","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1507\/endocrj.K05-137","article-title":"Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients","volume":"53","author":"Koga","year":"2006","journal-title":"Endocr. J."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0350","doi-asserted-by":"crossref","first-page":"e51098","DOI":"10.1371\/journal.pone.0051098","article-title":"Serum glycated albumin is inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0355","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2006.10.013","article-title":"Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels","volume":"378","author":"Koga","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0360","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1399-5448.2012.00895.x","article-title":"Glycated albumin is lower in infants than in adults and correlated with both age and serum albumin","volume":"14","author":"Suzuki","year":"2013","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0365","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s00125-011-2211-8","article-title":"Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus","volume":"54","author":"Suzuki","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0370","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-154-5-201103010-00004","article-title":"Racial differences in glycemic markers: a cross-sectional analysis of community-based data","volume":"154","author":"Selvin","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbagen.2013.05.010_bb0375","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0029-1238319","article-title":"A polymorphism within the fructosamine-3-kinase gene is associated with HbA1c levels and the onset of type 2 diabetes mellitus","volume":"118","author":"Moh\u00e1s","year":"2010","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0380","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2337\/dc08-0385","article-title":"Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients","volume":"31","author":"Stettler","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbagen.2013.05.010_bb0385","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/dc12-0787","article-title":"Alternative markers of hyperglycemia and risk of diabetes","volume":"35","author":"Juraschek","year":"2012","journal-title":"Diabetes Care"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416513002067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416513002067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T13:09:41Z","timestamp":1595768981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416513002067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":77,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0304416513002067"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2013.05.010","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycated albumin and diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2013.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}